PHAT Form 3: Sanjeev Narula reports zero holdings on 10/06/2025

Initial Form 3 filed for Sanjeev Narula.

Accepted by SEC EDGAR 10/07/2025 - 05:22 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Initial Form 3 filed for Sanjeev Narula. The filing reports a Date of Event of 10/06/2025 and identifies the reporting person as Sanjeev Narula with an address at 100 Campus Drive, Suite 102, Florham Park, NJ 07932. The form indicates the reporting person is an Officer with the title Chief Financial & Bus. Officer. The report discloses no non-derivative or derivative securities beneficially owned (listed as 0 and no securities are beneficially owned). The signature on the filing is by an attorney-in-fact dated 10/07/2025.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Narula Sanjeev

Role Chief Financial & Bus. Officer

Type	Security	Shares	Price	Value
Holding	No securities are beneficially owned.	--	--	--

Holdings: No securities are beneficially owned. — 0 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the PHAT Form 3 filed by Sanjeev Narula report?

The Form 3 reports that Sanjeev Narula is an Officer titled Chief Financial & Bus. Officer and discloses no beneficial ownership of Phathom Pharmaceuticals common stock.

What is the Date of Event on the PHAT Form 3 for Sanjeev Narula?

The Date of Event is 10/06/2025.

Does the Form 3 show any securities owned by Sanjeev Narula for PHAT?

No. The filing states "No securities are beneficially owned" and lists the amount as 0 shares (Direct).

Who signed the Form 3 for Sanjeev Narula and when?

The signature block shows "/s/ Anne Marie Cook, Attorney-in-Fact for Sanjeev Narula" dated 10/07/2025.

What address is listed for the reporting person on the PHAT Form 3?

100 Campus Drive, Suite 102, Florham Park, NJ 07932.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Narula Sanjeev

(Last) (First) (Middle)

C/O PHATHOM PHARMACEUTICALS, INC.

100 CAMPUS DRIVE, SUITE 102

(Street)

FLORHAM PARK NJ 07932

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/06/2025

3. Issuer Name and Ticker or Trading Symbol
Phathom Pharmaceuticals, Inc. [ PHAT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial & Bus. Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
No securities are beneficially owned.	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Anne Marie Cook, Attorney-in-Fact for Sanjeev Narula	10/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.